These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 35715969)

  • 1. Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.
    Michiels JJ; Berneman Z; Schroyens W; De Raeve H
    Acta Haematol; 2015; 133(1):36-51. PubMed ID: 25116092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The diagnosis and management of polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the JAK2 V617F era.
    Zhan H; Spivak JL
    Clin Adv Hematol Oncol; 2009 May; 7(5):334-42. PubMed ID: 19521323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-occurrence of JAK2 V617F-mutated essential thrombocythemia and chronic lymphocytic leukemia harboring der(8;17)(q10;q10).
    Manabe M; Tanizawa N; Nanno S; Hagiwara Y; Asada R; Koh KR
    Cancer Rep (Hoboken); 2022 Oct; 5(10):e1658. PubMed ID: 35715969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of the V617F JAK2 mutation in the lymphoid compartment in a patient with essential thrombocythemia and B-chronic lymphocytic leukemia and in two relatives with lymphoproliferative disorders.
    Musolino C; Allegra A; Penna G; Centorrino R; Cuzzola M; D'Angelo A; Iacopino P; Alonci A
    Acta Haematol; 2009; 122(1):46-9. PubMed ID: 19816006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.
    Henry L; Carillo S; Jourdan E; Arnaud A; Brun S; Lavabre-Bertrand T
    Am J Hematol; 2007 Jun; 82(6):500-1. PubMed ID: 17301972
    [No Abstract]   [Full Text] [Related]  

  • 6. Zap-70 positive chronic lymphocytic leukemia co-existing with Jak 2 V671F positive essential thrombocythemia: a common defective stem cell?
    Tabaczewski P; Nadesan S; Lim SH
    Leuk Res; 2009 Jun; 33(6):854-5. PubMed ID: 18849073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translocation t(1;9) is a recurrent cytogenetic abnormality associated with progression of essential thrombocythemia patients displaying the JAK2 V617F mutation.
    Leon A; Staropoli JF; Hernandez JM; Longtine JA; Kuo FC; Dal Cin P
    Leuk Res; 2011 Sep; 35(9):1188-92. PubMed ID: 21376394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. JAK2 V617F positive essential thrombocythemia developing in a patient with CD5⁻ chronic lymphocytic leukemia.
    Wei J; Wang C; Qin YW; Zhu J; Gao YR; Cai Q; Yan SK
    Chin Med J (Engl); 2012 Jun; 125(11):2076-9. PubMed ID: 22884083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Balanced and unbalanced translocations in a multicentric series of 2843 patients with chronic lymphocytic leukemia.
    Costa D; Granada I; Espinet B; Collado R; Ruiz-Xivillé N; Puiggros A; Uribe M; Arias A; Gómez C; Delgado J; Pereira A; Magnano L; Colomer D; López C; Beà S
    Genes Chromosomes Cancer; 2022 Jan; 61(1):37-43. PubMed ID: 34414624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic lymphocytic leukemia patients with IGH translocations are characterized by a distinct genetic landscape with prognostic implications.
    Pérez-Carretero C; Hernández-Sánchez M; González T; Quijada-Álamo M; Martín-Izquierdo M; Hernández-Sánchez JM; Vidal MJ; de Coca AG; Aguilar C; Vargas-Pabón M; Alonso S; Sierra M; Rubio-Martínez A; Dávila J; Díaz-Valdés JR; Queizán JA; Hernández-Rivas JÁ; Benito R; Rodríguez-Vicente AE; Hernández-Rivas JM
    Int J Cancer; 2020 Nov; 147(10):2780-2792. PubMed ID: 32720348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of lymphoid malignancies and Philadelphia-chromosome negative myeloproliferative neoplasms: Clinical characteristics, therapy and outcome.
    Masarova L; Newberry KJ; Pierce SA; Estrov Z; Cortes JE; Kantarjian HM; Verstovsek S
    Leuk Res; 2015 Aug; 39(8):822-7. PubMed ID: 26012362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic lymphocytic leukemia with t(14;18)(q32;q21).
    Tang G; Banks HE; Sargent RL; Medeiros LJ; Abruzzo LV
    Hum Pathol; 2013 Apr; 44(4):598-605. PubMed ID: 23084581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The coexistence of chronic lymphocytic leukemia and myeloproliperative neoplasms: a retrospective multicentric GIMEMA experience.
    Laurenti L; Tarnani M; Nichele I; Ciolli S; Cortelezzi A; Forconi F; Rossi D; Mauro FR; D'Arena G; Del Poeta G; Montanaro M; Morabito F; Musolino C; Callea V; Falchi L; Tedeschi A; Ambrosetti A; Gaidano G; Leone G; Foà R
    Am J Hematol; 2011 Dec; 86(12):1007-12. PubMed ID: 21953617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dic(17;18)(p11.2;p11.2) is a recurring abnormality in chronic lymphocytic leukaemia associated with aggressive disease.
    Woyach JA; Heerema NA; Zhao J; McFaddin A; Stark A; Lin TS; Andritsos LA; Blum KA; Flynn JM; Jones JA; Byrd JC
    Br J Haematol; 2010 Mar; 148(5):754-9. PubMed ID: 20015097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of 17p is a major consequence of whole-arm chromosome translocations in hematologic malignancies.
    Adeyinka A; Wei S; Sanchez J
    Cancer Genet Cytogenet; 2007 Mar; 173(2):136-43. PubMed ID: 17321329
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.